Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/9/2020
SIETES contiene 93097 citas

 
 
 1 a 20 de 27 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Leslie T, Mayan MI, Hasan MA, Safi MH, Klinkerberg E, Whitty CJM, Rowland M. Sulfadoxine-pyrimethamine, clorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan. A randomized controlled trial. JAMA 2007;297:2201-9. [Ref.ID 80170]
2.
Whitty CJM, Rowland M, Sanderson F, Mutabingwa TK. Malaria. BMJ 2002;325:1221-4. [Ref.ID 64182]
3.
Rowland M, Durrani N, Kenward M, Mohammed N, Urahman H, Hewitt S. Control of malaria in Pakistan by applying deltamethrin insecticide to cattle: a community-randomised trial. Lancet 2001;357:1837-41. [Ref.ID 57239]
4.Tiene citas relacionadas
Rowland M. Transmission of Helicobacter pylori: is it all child's play?. Lancet 2000;355:332-3. [Ref.ID 49093]
5.
Vozeh S, Steimer JL, Rowland M, Morselli P, Mentrè F, Balant LP, Aarons L. The use of population pharmacokinetics in drug development. Clin Pharmacokinet 1996;30:81-93. [Ref.ID 26018]
6.
Aarons L, Balant LP, Mentré F, Morselli PL, Rowland M, Steimer JL, Vozeh S. Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies. Eur J Clin Pharmacol 1996;49:251-4. [Ref.ID 25808]
7.
Gill TS, Hopkins KJ, Rowland M. Stereospecific assay of nicoumalone: application to pharmacokinetic studies in man. Br J Clin Pharmacol 1988;25:591-8. [Ref.ID 11702]
8.
Gill TS, Hopkins KJ, Rowland M. Nicoumalone-cimetidine interaction in man: stereochemical considerations. Br J Clin Pharmacol 1986;21:564P-5P. [Ref.ID 9618]
9.
Rowland M, Tucker G. Symbols in pharmacokinetics. J Pharmacokinet Biopharm 1980;8:497-507. [Ref.ID 5769]
10.
Pang KS, Rowland M, Tozer TN. In vivo evaluation of Michaelis-Menten constants of hepatic drug-eliminating systems: a commentary. Drug Metab Dispos 1978;6:197-200. [Ref.ID 4604]
13.
Aarons LJ, Bochner F, Rowland M. A chronic dose-ranging kinetic study of salicylate in man. Br J Pharmacol 1977;61:456P-7P. [Ref.ID 3175]
14.
Williams RL, Blaschke TF, Meffin PJ, Melmon KL, Rowland M. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide. Clin Pharmacol Ther 1977;21:301-9. [Ref.ID 2944]
15.
Ueda CT, Ballard BE, Rowland M. Concentration-time effects on quinidine disposition kinetics in Rhesus monkeys. J Pharmacol Exp Ther 1977;200:459-68. [Ref.ID 2310]
16.
Rowland M, Benet LZ, Graham GG. Clearance concepts in pharmacokinetics. J Pharmacokinet Biopharm 1973;1:123-36. [Ref.ID 1768]
17.
Rowland M, Thomson PD, Guichard A, Melmon KL. Disposition kinetics of lidocaine in normal subjects. Ann N Y Acad Sci 1971;179:383-98. [Ref.ID 464]
19. Cita con resumen
Riegelman S, Loo J, Rowland M. Concept of a volume of distribution and possible errors in evaluation of this parameter. J Pharm Sci 1968;57:128-33. [Ref.ID 231]
20. Cita con resumen
Thomson PD, Melmon KL, Richardson J A, Cohn K, Steinbrunn W, Cudihee R, Rowland M. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med 1973;78:499-508. [Ref.ID 169]
Seleccionar todas
 
 1 a 20 de 27 siguiente >>